Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Acta Neurológica Colombiana
versión impresa ISSN 0120-8748versión On-line ISSN 2422-4022
Resumen
MARENTES-CUBILLOS, Alba Lucia; CARRILLO-VILLA, Sandra; LOPEZ-CACERES, Andrea del Pilar y MESA-MOSQUERA, Maria Paula. Diagnostic aids and differential diagnosis of Pompe disease. Acta Neurol Colomb. [online]. 2023, vol.39, n.2, e3. Epub 02-Nov-2023. ISSN 0120-8748. https://doi.org/10.22379/anc.v39i2.1751.
Introduction:
Pompe disease (PD) or Glycogenosis Type II is a rare autosomal recessive disease caused by mutations in the GAA gene that codes for the alpha-1,4-glucosidase protein. Its deficiency leads to abnormal glycogen storage in the lysosomes of various cells throughout the different tissues causing a predominant musculoskeletal compromise.
Contents:
The phenotypes of the disease depend on the genetic variants and the levels of residual enzyme activity, presenting as infantile-onset PD, late-onset PD, and intermediate PD; Therefore, early diagnosis of the disease through molecular studies such as Sanger sequencing and new generation sequencing is of utmost importance.
Conclusions:
It has been shown through different studies that genetic variations can vary between ethnic groups and the molecular characterization of the variants is important to determine the most appropriate treatment depending on the state of the cross-reactive immunological material (CRIM)
Palabras clave : Molecular diagnosis; Pompe disease; Fibroblasts; Leukocytes; Electron microscopy; GAA; Genetic variant.